Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MET | P08581 | 8/20 | 0.73 |
| ▸ | MERTK | Q12866 | 5/20 | 0.52 |
| ▸ | AXL | P30530 | 4/20 | 0.50 |
| ▸ | L3MBTL3 | Q96JM7 | 6/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.45 |
| ▸ | MBTD1 | Q05BQ5 | 4/20 | 0.45 |
| ▸ | ATR | Q13535 | 1/20 | 0.45 |
| ▸ | TP53BP1 | Q12888 | 1/20 | 0.45 |
| ▸ | L3MBTL4 | Q8NA19 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL488099 | 1.00 | MET (0.73) | METMERTKAXLL3MBTL3L3MBTL1 | |
| SCHEMBL488487 | 0.88 | MET (0.82) | METMERTKAXL | |
| SCHEMBL30452768 | 0.88 | MET (0.82) | METMERTKAXL | |
| SCHEMBL10216184 | 0.88 | MET (0.79) | METMERTKAXLL3MBTL3L3MBTL1 | |
| SCHEMBL487881 | 0.88 | MET (0.81) | METMERTKAXLL3MBTL3L3MBTL1 | |
| SCHEMBL30453513 | 0.88 | MET (0.81) | METMERTKAXLL3MBTL3L3MBTL1 | |
| SCHEMBL5256038 | 0.87 | MET (0.83) | METMERTKAXL | |
| SCHEMBL5255609 | 0.86 | MET (0.70) | METMERTKAXLL3MBTL3L3MBTL1 | |
| SCHEMBL488118 | 0.85 | MET (0.91) | METMERTKAXL | |
| SCHEMBL5256618 | 0.85 | MET (0.86) | METMERTKAXL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113181362-B | Medicament for preventing and/or treating amyotrophic lateral sclerosis | 国立大学法人京都大学 | 2023-06-13 | — | — | CN | disclosed |